RE:RE:RE:RE:Great opportunity!For the First 3 quarters of 2022:
Operation cash ouflow was $19.8m before balance sheet items.
During that period, R&D was $27.5m
They would need to scrap 25% of their R&D to achieve breakeven, 55% to achieve $10m Net Operating Cash Flow.
Some cuts in the SG&A ($72.5m in the first three quarters) would make sense but seems well protected.
It won't happen until they have no choice. By then, scavengers will fly low.